![]() | Digihealth (DGH) |
Status
IDO
Digipharm manage and process performance-based healthcare procurement agreements for healthcare organisations that enable payment for healthcare technologies and services based on how well they work.
Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is Digihealth
Reimburse is Digipharm’s flagship software solution that aims to create a platform where key stakeholders in the healthcare system can perform transactions through value-based agreements. The platform’s utility is multi-pronged, with benefits that apply to healthcare practitioners, manufacturers, vendors, and patients.As a healthcare service provider, Reimburse can help you tap into real-world analytics to qualify patient eligibility for services, develop value-based pricing systems, and implement secure pay-for-performance healthcare agreements.
The platform will enable you to continue providing access to needed health technologies and interventions while maintaining strict control over your budget.
Digipharm develops innovative digital solutions for improving service delivery in health systems. The company has offices in London, England, and Basel, Switzerland. Aside from Reimburse, Digipharm also provides a wide range of healthcare services and products, including the Digihealth patient software application, which incentivizes patients to take part in clinical evaluations and other assessments.
Digihealth Roadmap
1
- DGH Platform utility and access
2
Q3 2022
- BNB Chain Migration
3
Q4 2022
- CEX listing
4
Q1 2023
- Digihealth Launch
- Patient and user rewards
- Community governance and rewards program
5
TBC
- Payment functionality: DIGIPHARM payment card, DGH payment capability for healthcare services, Digihealth Store (Subject to terms and conditions)
Token Sale Dates
IDO
Start date: Oct 20, 2022
End date: Oct 28, 2022
IDO
Start date: Nov 01, 2022
End date: Nov 05, 2022
IDO
Start date: Dec 01, 2022
End date: Dec 01, 2022
Token Allocation
Total Token Supply 100,000,000 DGH
Token distribution
50% - Public sale
15% - Team & investors
15% - Marketing, partners and pilots
20% - Platform and ecosystem development
Token Price and Payment Options
Token price USD 1 DGH = 0.05 USD
Project team

Ahmed Abdulla
Founder/CEO

Mike Smith
Chief Technology Officer

Steven Sibert
IT Systems Administrator

Mohamed Ghaleb
Clinical Informaticist (Medical Systems)

Dr Mohamed Abdulla
Chief Medical Officer

Adel Almofadaly
Regional Director MENA

Mohammed Rahman
Chief Operations Officer

Isaam Mirza
Partnership and Engagement Manager

Alexey Popov
Web Engineering

Ali Al-Sudani
Clinical Pharmacist

Marko Granic
Graphic Designer
Advisors

Lucas C.
Business Advisor

Faraz M.
Strategic Equity Partner










